U.S. pharmaceutical manufacturers weakened in pre-market trading, with AstraZeneca (AZN.O) down more than 3%, GlaxoSmithKline (GSK.N) down more than 2.6%, Amgen down 2.6%, Gilead Sciences (GILD.O) down 2%, and Eli Lilly (LLY.N) down 1.4%.

2026-11-06

U.S. pharmaceutical manufacturers weakened in pre-market trading, with AstraZeneca (AZN.O) down more than 3%, GlaxoSmithKline (GSK.N) down more than 2.6%, Amgen down 2.6%, Gilead Sciences (GILD.O) down 2%, and Eli Lilly (LLY.N) down 1.4%.